TT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Trane Technologies PLC is not an immediate buy for a beginner investor with a long-term focus. While the company has strong growth prospects and positive analyst sentiment, the recent insider selling, slight decline in financial performance metrics, and lack of a strong proprietary trading signal suggest waiting for a better entry point.
The stock is in a bullish trend with moving averages (SMA_5 > SMA_20 > SMA_200) and a positive MACD histogram of 3.531. However, the RSI_6 at 78.557 is in the neutral zone, indicating no clear overbought or oversold conditions. Key resistance levels are at R1: 486.186 and R2: 495.13, with support at S1: 457.23.
Analysts have a positive outlook, with multiple firms raising price targets and maintaining Outperform or Overweight ratings.
The company has a strong backlog and secular growth exposure, with Evercore predicting 8% organic growth and double-digit earnings growth annually through
Recent news highlights significant revenue growth and a strong order backlog.
Insiders have been selling heavily, with a 143.90% increase in selling activity over the last month.
Q4 financials showed a decline in net income (-2.15% YoY), EPS (-0.75% YoY), and gross margin (-2.88% YoY), indicating some operational challenges.
Hedge funds are neutral, and there are no significant trading trends in the last quarter.
In Q4 2025, revenue increased by 5.55% YoY to $5.14 billion, but net income dropped by 2.15% YoY to $591.3 million. EPS also declined slightly by 0.75% YoY to 2.64, and gross margin fell by 2.88% YoY to 34.09%. While revenue growth is positive, the decline in profitability metrics raises concerns.
Analysts are generally bullish on Trane Technologies. KeyBanc raised its price target to $525, citing improved Q1 demand. Evercore ISI initiated coverage with an Outperform rating and a $535 price target, highlighting the company's best-in-class commercial HVAC platform and strong growth potential. However, Goldman Sachs lowered its price target to $473, maintaining a Neutral rating, reflecting some caution.
